CLINICAL STUDY-2018, SMR: Penile Traction Therapy and Vacuum Erection Devices in Peyronie’s Disease. Conclusions: Penile Traction Therapy and Vacuum Erection Devices represent viable therapeutic options for managingPeyronie’s Disease, with more data currently available onPenile Traction Therapy (PTT). Because all PTT studies used a similar style of traction device, it is unclear whether results reflect outcomes of these particular devices or traction more broadly.

Abstract

Introduction

Peyronie’s disease (PD) has historically been managed by at least 1 treatment, including oral supplements or medications, intralesional injections, or surgery. Adjunctive mechanical therapies also have been described, including penile traction therapy (PTT) and vacuum erection devices (VEDs), although relatively limited data are available on their use with PD.

Aim

To review and summarize the published literature on the role and efficacy of PTT and VED in men with PD.

Methods

A PubMed search was performed of all publications on PTT and VED in men with PD from inception through September 2017.

Main Outcome Measures

Changes in penile curvature, length, girth, erectile function, and adverse eventswith PTT or VED.

Results

PTT and VED exhibit mechanisms to improve aspects of PD, although clinical outcomes data are limited. Based on current data, PTT likely has a potential role as a primary lengthening therapy (modest improvements), in curvature correction (acute phase; unclear role in chronic phase), before penile prosthesis insertion, and after surgical correction of PD. The role of PTT as a combination therapyduring collagenase Clostridium histolyticum injections is unclear. Fewer and lower level-of-evidence studies are available on VEDs and suggest potential roles in curvature correction, before penile prosthesis placement, or after PD surgery. Guideline statements from the American Urological Association and International Consultation on Sexual Medicine also support the potential role of PTT and VED in managing PD.

Conclusions

PTT and VED represent viable therapeutic options for managing PD, with more data currently available on PTT. Because all PTT studies used a similar style of traction device, it is unclear whether results reflect outcomes of these particular devices or traction more broadly. Further studies are required to better delineate the benefits of PTT and VED, particularly in relation to other established treatments.

Avant RA, Ziegelman M, Nehra A, et al. Penile Traction Therapy and Vacuum Erection Devices in Peyronie’s Disease. Sex Med Rev 2018;X:XXX–XXX.

Kewyords:

Andropenis, Xiaflex, Collagenase, Curvature, Length

Source:

https://www.sciencedirect.com/science/article/pii/S2050052118300192
Andropeyonie penis extender device for Peyronie disease
andro-peyronie

€199 / $199
149 £ / 249 AU$-CA$

FREE SHIPPING

andropharma curvature pills

€99 / $99
85 £ / 149 AU$-CA$

FREE SHIPPING